Revance Therapeutics Vs. Target Industry Stock Comparison

Sell

10

RVNC
Revance Therapeutics

Last Price:

3.85

Seasonality Move:

2.15%

Sell

20

TGT
Target

Last Price:

124.84

Seasonality Move:

4.08%

Sell

10

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

20

Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $3.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

TGT Stock Price Chart

What is Target's stock price today?

The Target share price today is $121.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.44	Sell
Relative Strength Index (14 RSI):	34.28	Sell
Chaikin Money Flow:	227722	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.06 - 5.8)	Sell
Bollinger Bands (100):	(3.74 - 6.28)	Sell

TGT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.85	Sell
Relative Strength Index (14 RSI):	23.91	Sell
Chaikin Money Flow:	-8404826	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(140.56 - 157.62)	Sell
Bollinger Bands (100):	(142.35 - 156.95)	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.03	Sell
20-day SMA:	4.84	Sell
50-day SMA:	5.22	Sell
200-day SMA:	4.61	Sell
8-day EMA:	4.07	Sell
20-day EMA:	4.56	Sell
50-day EMA:	4.97	Sell
200-day EMA:	6.03	Sell

TGT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	146.51	Sell
20-day SMA:	148.61	Sell
50-day SMA:	151.64	Sell
200-day SMA:	153.85	Sell
8-day EMA:	141.24	Sell
20-day EMA:	147.16	Sell
50-day EMA:	149.8	Sell
200-day EMA:	149.63	Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Target Earnings Growth & TGT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Revance Therapeutics Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):